OrthoPediatrics Corp (KIDS) stock
KIDSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/308% below fair value
$31.65+0.24 (+0.76%)
Close on Nov 18, 2026Market cap $826.40MP/E –Yield –
OrthoPediatrics cash
Cash and short-term investments held at the end of each period.
OrthoPediatrics's cash was $44.23M at Sep 30, 2026. For fiscal 2025 it was $60.85M, down 14.0% from the year before. Over ten years it grew 31.7% a year on average. The highest annual figure on record is $119.76M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $60.85M | -14.0% |
| FY2024 | Dec 31, 2024 | $70.79M | -14.0% |
| FY2023 | Dec 31, 2023 | $82.28M | -31.3% |
| FY2022 | Dec 31, 2022 | $119.76M | +118.1% |
| FY2021 | Dec 31, 2021 | $54.91M | -35.6% |
| FY2020 | Dec 31, 2020 | $85.27M | +18.4% |
| FY2019 | Dec 31, 2019 | $72.03M | +18.7% |
| FY2018 | Dec 31, 2018 | $60.69M | +42.5% |
| FY2017 | Dec 31, 2017 | $42.58M | +2546.5% |
| FY2016 | Dec 31, 2016 | $1.61M | -58.5% |
| FY2015 | Dec 31, 2015 | $3.88M | -41.1% |
| FY2014 | Dec 31, 2014 | $6.58M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $44.23M | -26.0% |
| Q2 FY2026 | Jun 30, 2026 | $45.88M | -36.5% |
| Q1 FY2026 | Mar 31, 2026 | $48.81M | -19.7% |
| Q4 FY2025 | Dec 31, 2025 | $60.85M | -14.0% |
| Q3 FY2025 | Sep 30, 2025 | $59.79M | -23.4% |
| Q2 FY2025 | Jun 30, 2025 | $72.20M | +133.7% |
| Q1 FY2025 | Mar 31, 2025 | $60.76M | +22.2% |
| Q4 FY2024 | Dec 31, 2024 | $70.79M | -14.0% |
| Q3 FY2024 | Sep 30, 2024 | $78.06M | -7.1% |
| Q2 FY2024 | Jun 30, 2024 | $30.89M | -67.4% |
| Q1 FY2024 | Mar 31, 2024 | $49.71M | -54.5% |
| Q4 FY2023 | Dec 31, 2023 | $82.28M | -31.3% |
| Q3 FY2023 | Sep 30, 2023 | $84.01M | -30.9% |
| Q2 FY2023 | Jun 30, 2023 | $94.78M | +80.5% |
| Q1 FY2023 | Mar 31, 2023 | $109.21M | +135.4% |
| Q4 FY2022 | Dec 31, 2022 | $119.76M | +118.1% |
| Q3 FY2022 | Sep 30, 2022 | $121.58M | +105.9% |
| Q2 FY2022 | Jun 30, 2022 | $52.52M | -21.9% |
| Q1 FY2022 | Mar 31, 2022 | $46.39M | -40.5% |
| Q4 FY2021 | Dec 31, 2021 | $54.91M | -35.6% |
| Q3 FY2021 | Sep 30, 2021 | $59.05M | -34.2% |
| Q2 FY2021 | Jun 30, 2021 | $67.22M | -40.5% |
| Q1 FY2021 | Mar 31, 2021 | $78.00M | +45.6% |
| Q4 FY2020 | Dec 31, 2020 | $85.27M | +18.4% |
| Q3 FY2020 | Sep 30, 2020 | $89.74M | +356.3% |
| Q2 FY2020 | Jun 30, 2020 | $113.05M | +417.2% |
| Q1 FY2020 | Mar 31, 2020 | $53.58M | +1.5% |
| Q4 FY2019 | Dec 31, 2019 | $72.03M | +18.7% |
| Q3 FY2019 | Sep 30, 2019 | $19.67M | -19.6% |
| Q2 FY2019 | Jun 30, 2019 | $21.86M | -17.5% |
| Q1 FY2019 | Mar 31, 2019 | $52.77M | +52.6% |
| Q4 FY2018 | Dec 31, 2018 | $60.69M | +42.5% |
| Q3 FY2018 | Sep 30, 2018 | $24.46M | +993.1% |
| Q2 FY2018 | Jun 30, 2018 | $26.51M | +1049.4% |
| Q1 FY2018 | Mar 31, 2018 | $34.59M | +1314.2% |
| Q4 FY2017 | Dec 31, 2017 | $42.58M | +2546.5% |
| Q3 FY2017 | Sep 30, 2017 | $2.24M | – |
| Q2 FY2017 | Jun 30, 2017 | $2.31M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.45M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.61M | – |
See a number that looks wrong?